AlphAIalphai — Financial news for AI agents
FinvizMAY 14 min read$OPCH

OPCH - Option Care Health Inc Stock Price and Quote

Option Care Health Inc. (OPCH) saw its stock close down significantly after cutting its 2026 revenue outlook due to a larger Stelara reset, despite maintaining its EBITDA/EPS guidance. The article provides comprehensive financial data, analyst ratings history, and recent news headlines related to the company's performance, including insider transactions.

Original reporting
Finviz
Published May 1, 2026, 1:39 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 1, 2026, 2:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefFinancial news
Primary signal
$OPCH
Bearish
medium confidence
Mentioned
$OPCH
alphai data visualization · based on Finviz
Decision brief

The 30-second read

$OPCHBearishLow
01

Why it matters

The revenue revision has led to a bearish market reaction, impacting stock price and possibly investor sentiment in the sector.

02

Market read

The news is highly relevant for traders holding or considering OPCH, with potential short-term downside risk.

03

What to watch

Potential positive catalysts include upcoming earnings reports, new contracts, or strategic initiatives that could offset current concerns.

Timing: short-term

Background

Option Care Health Inc. is a healthcare provider specializing in infusion services. Recent news indicates a revenue outlook cut due to a larger Stelara reset, affecting investor confidence.

Company-level read

Ticker impact

$OPCHBearishMedium confidence
Context

High relevance due to recent stock performance and outlook revision.

Expected impact

Potential further decline in stock price in the short term, with possible stabilization if company manages to reassure investors.

Evidence & confidence

The stock's recent decline and revenue outlook revision indicate negative market sentiment, but the maintained EBITDA/EPS guidance suggests some resilience. Technical indicators are not available, but the recent price action supports a cautious outlook.

Market effects

Sector

Negative sentiment may impact healthcare and life sciences sectors, especially companies with similar revenue sensitivities.

Regional

Limited to US markets where OPCH is listed.

Global

Minimal, as OPCH is a regional player with limited global exposure.

Counterpoint

What could challenge this read

The revenue outlook revision may be a short-term reaction; fundamentals remain intact, and the stock could rebound if the company provides positive guidance or clarification.

Key entities

  • Company
    Option Care Health Inc.

    A healthcare provider specializing in infusion and pharmacy services.

  • Product
    Stelara

    A medication whose larger reset has impacted OPCH's revenue outlook.

Read at source← All news

Related articles

JUL 31
$OPCHMed

Option Care Health, Inc. Q2 2026 Earnings Call Summary

Strategic Execution and Portfolio Recovery Performance beat driven by high-single-digit organic growth in the acute portfolio, where the company's national scale and local responsiveness facilitate time-sensitive hospital discharges. The chronic inflammatory disease (CID) portfolio reached a stabilization point following a first-quarter reset, with patient census beginning to rise sequentially despite biosimilar pricing headwinds.

yahoo.com6 min
JUL 29
$OPCHMedAI 8/10

Option Care Health (NASDAQ:OPCH) Posts Better

Option Care Health (OPCH) reported Q2 CY2026 revenue of $1.44 billion, up 1.9% year over year, beating Wall Street’s expectations. The company guided full-year revenue to about $5.73 billion. Non-GAAP profit was $0.45 per share, 5.4% above consensus. Shares rose about 6.5% to $23.95 after the release.

financialcontent.com5 min
JUL 29
$OPCHMed

Option Care Health, Inc. (OPCH): Results of Operations and Financial Condition

Option Care Health, Inc. (OPCH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991-q22026.htm EX-99.1 Document Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2026 BANNOCKBURN, IL., July 29, 2026 - Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s

SEC EDGAR 8-K4 min
JUN 9
$OPCHMed

Option Care Health (OPCH) Stock Trades Up, Here Is Why

Option Care Health shares rose about 3.7% in the morning after Goldman Sachs initiated coverage with a Neutral rating and a $22 price target, implying upside from around $20.51. The stock had fallen 33% over six months. The article notes the company recently reported Q1 2026 revenue of $1.35B (+1.3% YoY) and cut full-year revenue guidance to a $5.73B midpoint.

markets.financialcontent.com4 min
AUG 9
$LMTMedAI 8/10

What is Patriot missile system, why its supplies are down

The article explains the U.S.-made Patriot mobile air defense system and why interceptor missile supplies are down. It cites Raytheon and Lockheed for system details and notes CSIS estimates about 65% of U.S. interceptors were expended Feb to July, leaving under 850. It says the U.S. approved 5,250 interceptors for Gulf states and awarded Lockheed a contract up to $58.6B.

dailysabah.com6 min
AUG 9
$ETNMed

Eaton Gains on $7-Million Contract

Eaton (NYSE:ETN) said the U.S. Air Force Research Laboratory awarded it a $7 million, 24-month contract to use quantum computing, machine learning, and advanced visualization to improve power grid resilience and protection. The work, with Infleqtion and Penn State, targets detection and response to multiple concurrent physical and cyber threats, addressing NERC N-2 contingency requirements.

baystreet.ca3 min